Giulio Filippo Giacomo Tarro, graduated summa cum laude from Naples University (N.U.) in 1962. Assistant to Medical Pathology at N.U., 1963-1965, and Research Associate at Division of Virology and Cancer Research, Children’s Hospital, Cincinnati, Ohio, 1965-1968, and then assistant professor of Research Pediatrics, 1968-1969, Professor of Oncological Virology at N.U. 1972-1985. He worked for CNR, Rome, 1969-1972, and for NCI, Frederick Center, Maryland, 1973. He became Division Chief of Virology 1973-2003, and then Department Chief of Diagnostic Laboratories, 2003-2006, D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006. His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Achievements include patents in field; discovery of vibrio cholera in 1973 during Naples epidemy, of RSV virus in infant deaths in Naples 1979 and of tumor liberated protein (TLP) as a tumor associated antigen, 50 kilodalton, overexpressed in lung tumors and other epithelial adenocarcinomas. Scientific Coordinator extracorporeal hyperthermia in HCV patients, First Circle Medicine, Minneapolis., 2000-03. Since 2007 he is Chairman Committee on VirusSphere (WABT). Dr. Tarro is on the editorial board of various medical journals and has been elected to membership and/or presidence of many academies and societies. Recipient of many awards and honours. Adjunct Professor Department Biology Temple University, Philadelphia, and lifetime achievement award, 2010. Since 2015 Editor in Chief, Journal of Vaccine Research and Development, Singapore. Life President Foundation Teresa & Luigi de Beauont Bonelli for Cancer Research, DORSO award with Italian President plate given at Republic Senate (Rome 2019).

Cheepsattayakorn graduated Doctor of Medicine from Chiang Mai Medical School, Chiang Mai University, Chiang Mai, Thailand in 1986. He then further had trained in Internal Medicine, Pulmonology, and Radiology at Chiang Mai University Medical School. Recently, on October 26, 2019, he was bestowed the Gold Medal Award (First-Class Award) from the Chiang Mai University Medical School Alumni Association in Chiang Mai, Thailand for his academic and medical practice excellence for cerebrating the 60th Anniversary of the Chiang Mai University Medical School, Chiang Mai, Thailand that was established on October 28, 1959. He graduated numerous Fellowships from the Royal Colleges of Physicians of Edinburgh, London and Thailand, Royal College of Physicians and Surgeons of Glasgow, American College of Physicians, and American College of Chest Physicians. Presently, he serves both Editor and Editorial Board Member, referee of several international journals, and several international conference organizing committees. He has very high experience in the fields of pulmonary diseases and Tuberculosis including Infectious Diseases and Immunology. He has numerous scientific publications, more than 330 publications both in national and international journals and books, including authored textbook of COVID-19, “Thailand’s and Global Perspectives of COVID-19”, both the United Kingdom version (361 pages, first edition published by the Medical and Research Publications in 2021) and the United States of America version (367 pages, second edition published by the Science and Education Publishing in 2022). Recently, in 2022, he published a Book Chapter, entitled “COVID-19 and Respiratory System” in a Textbook, entitled “Chest Medicine in Perspective” published by Thammasat Printing House, Bangkok, Thailand (736 pages). He had been served a Director and Consultant in Respiratory Medicine of the 10th Zonal Tuberculosis and Chest Diseases Center, Chiang Mai, Thailand for a long time, a Director of the 5th Office of Disease Prevention and Control and Consultant in Respiratory Medicine, Ratchaburi, Thailand and presently serves as Consultant in Respiratory Medicine (Pulmonologist) at the 10th Zonal Tuberculosis and Chest Diseases Center, Chiang Mai, Thailand and Senior Expert Level 11 (Highest Level, equivalent to Professor of Medicine Level 11), Department of Disease Control, Ministry of Public Health, Thailand. He serves as Instructor of the Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand and Faculty Member of the Faculty of Medicine, Western University. Currently, he also serves the International Regional Adviser (Advisory Board) for Thailand of the Royal College of Physicians of Edinburgh, United Kingdom and the Reviewer for the journals of the Royal College of Physicians of London, United Kingdom. He was appointed the Japan International Cooperation Agency (JICA)’s Advisor in 2021-2022. He was directly invited & proposed to the World Federation of United Nations Associations (WFUNA) Membership by the United Nations Former Secretary-General “H.E. Ban Ki-Moon”. Recently, he has been approved for the Membership of the WFUNA since 4 January 2022 (Ref.: UN-467-NYUN) and has been appointed the WFUNA Membership signed by the UN authorities (the UN Secretary-General, the UN President of the General Assembly, and the UN President of the Security Council) since January 15, 2022. Nationally, recently, he was appointed the chairman of the executive research ethical board committee for the health inspection region 4, Thailand Ministry of Public Health since September 5, 2022 and nationally, recently, he was appointed a board committee director for urban disease control academic planning since August 26, 2022. Since March 31, 2023, he has been appointed an executive committee member of the Anti-Tuberculosis Association of Thailand under The Royal Patronage of H.M. The King (Bangkok). Recently, he was appointed the Secretary-General of the Urban Disease Control Foundation, Thailand.

Dr. Susu Zughaier is an Associate Professor of Microbiology and Immunology and the Chair of Infectious Diseases Research Network at Qatar University College of Medicine. Trained as a clinical microbiologist at University College London; MSc and PhD in Microbiology and Immunology from Cardiff University, UK. Postdoctoral training at Harvard Medical School in Boston, USA and was Assistant Professor of Microbiology and Immunology, Emory University School of Medicine in Atlanta, USA. Her research interests are focused on antimicrobial resistance, host-pathogen interactions, nanovaccine development, nanotechnology for rapid detection of bacterial infections and artificial intelligence for medical applications. Her translational research is focused on vitamin D immune modulatory effects and related translational studies. Dr. Zughaier published more than 120 scientific research papers with H-index 38 and awarded four patents on her discoveries. She has been listed among the top 2% of highly cited authors with impact in their field in 2020 and 2024. She is an active member of various international societies and serves as Associate Editor, Editorial board member and ad-hoc reviewer for multiple international journals.